Buys and Sellers Biggest Seller ANONYMOUS

APH is tied to Weed because what happens to weed happens to the sector and the BIGGEST sell fast

Look at Weed they have been hit hard...so the WHOLE sector is down.3Lookk at this DUMP of shares before the long weekend...

Biggest Sellers Of Weed

House Positions for C:WEED from 20180629 to 20180629

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
90 Barclays	300	11,702	39.007	385,300	14,951,663	38.805	-385,000	14,939,961
9 BMO Nesbitt	779,721	30,271,099	38.823	993,626	38,798,918	39.048	-213,905	8,527,819
53 Morgan Stanley	38,837	1,511,293	38.914	233,426	9,005,971	38.582	-194,589	7,494,678
59 PI	12,650	482,539	38.145	121,054	4,694,645	38.781	-108,404	4,212,106
39 Merrill Lynch	379,725	14,797,625	38.969	456,701	17,725,755	38.813	-76,976	2,928,130
101 SG Capital	20,700	808,083	39.038	55,200	2,127,916	38.549	-34,500	1,319,833
1 Anonymous	2,894,650	112,645,676	38.915	2,923,506	113,898,811	38.96	-28,856	1,253,135
14 ITG	3,007	119,041	39.588	25,130	981,550	39.059	-22,123	862,509
65 Goldman	10,205	394,383	38.646	28,300	1,100,164	38.875	-18,095	705,781
72 Credit Suisse	851	32,462	38.146	13,300	517,873	38.938	-12,449	485,411
143 Pershing	13,328	523,599	39.286	22,306	866,940	38.866	-8,978	343,341

Biggest Sellers Of APH

House Positions for C:APH from 20180629 to 20180629

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
79 CIBC	1,237,292	14,791,242	11.955	1,614,568	19,322,402	11.968	-377,276	4,531,160
1 Anonymous	1,590,819	19,040,165	11.969	1,853,106	22,174,425	11.966	-262,287	3,134,260
72 Credit Suisse	14	165	11.786	146,500	1,752,172	11.96	-146,486	1,752,007
53 Morgan Stanley	87,662	1,054,570	12.03	231,000	2,743,068	11.875	-143,338	1,688,498
62 Haywood	0			87,740	1,052,174	11.992	-87,740	1,052,174
39 Merrill Lynch	137,184	1,640,426	11.958	168,704	2,027,328	12.017	-31,520	386,902
13 Instinet	5,995	72,532	12.099	32,005	394,646	12.331	-26,010	322,114
48 Laurentian	0			24,900	296,997	11.928	-24,900	296,997
14 ITG	19,265	227,089	11.788	30,000	361,021	12.034	-10,735	133,932
89 Raymond James	4,262	50,777	11.914	12,000	142,782	11.899	-7,738	92,005
33 Canaccord	173,830	2,079,206	11.961	181,362	2,168,317	11.956	-7,532	89,111
74 GMP	1,500	17,955	11.97	6,800	84,120	12.371	-5,300	66,165
28 BBS	1,856	22,223	11.974	2,900	35,403	12.208	-1,044	13,180
57 Interactive	895	10,635	11.883	1,430	17,053	11.925	-535	6,418
83 Mackie	251	2,991	11.916	0			251	-2,991
15 UBS	4,391	53,698	12.229	4,100	49,214	12.003	291	-4,484
101 SG Capital	300	3,603	12.01	0			300	-3,603
56 Edward Jones	445	5,275	11.854	0			445	-5,275
76 Industrial Alliance	500	5,935	11.87	0			500	-5,935
36 Latimer	6,047	71,901	11.89	5,290	63,215	11.95	757	-8,686
143 Pershing	15,064	181,946	12.078	14,264	173,489	12.163	800	-8,457
99 Jitney	101,200	1,211,199	11.968	99,700	1,196,567	12.002	1,500	-14,632
70 Manulife	3,400	40,408	11.885	0			3,400	-40,408
65 Goldman	6,100	72,277	11.849	2,500	29,603	11.841	3,600	-42,674
88 Credential	3,933	46,902	11.925	200	2,436	12.18	3,733	-44,466
24 Clarus	5,000	60,701	12.14	0			5,000	-60,701
59 PI	5,048	60,070	11.90	0			5,048	-60,070
58 Qtrade	15,661	189,118	12.076	3,810	46,023	12.08	11,851	-143,095
19 Desjardins	32,197	384,829	11.952	12,489	150,277	12.033	19,708	-234,552
22 Fidelity	36,923	443,413	12.009	8,785	106,173	12.086	28,138	-337,240
80 National Bank	63,736	776,443	12.182	21,700	258,305	11.903	42,036	-518,138
124 Questrade	193,362	2,312,320	11.959	137,648	1,654,773	12.022	55,714	-657,547
9 BMO Nesbitt	185,686	2,223,451	11.974	86,695	1,042,591	12.026	98,991	-1,180,860
2 RBC	487,187	5,839,353	11.986	382,146	4,575,362	11.973	105,041	-1,263,991
85 Scotia	523,772	6,271,543	11.974	311,493	3,744,078	12.02	212,279	-2,527,465
7 TD Sec	989,334	11,860,897	11.989	456,276	5,461,244	11.969	533,058	-6,399,653
TOTAL	5,940,111	71,125,258	11.974	5,940,111	71,125,258	11.974	0	0

Aphria Signs Supply Agreement With Manitoba

Aphria Signs Supply Agreement with MBLL to Supply Up to 2.7 Million Grams of Cannabis to the Manitoba Adult-Use Market

Canada NewsWire

LEAMINGTON, ON, June 29 2018

The Company will provide a wide range of adult-use brands and products to be sold at licensed retailers across the province

LEAMINGTON, ON, June 29 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the "Agreement") with the Manitoba Liquor and Lotteries Corporation ("MBLL") to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in Manitoba's adult-use market.

"We are thrilled to finalize this Agreement with the MBLL," said Jakob Ripshtein, Chief Commercial Officer at Aphria. "Our broad portfolio of adult-use brands and products has been specifically developed to meet the needs of distinct consumer segments, whether new to cannabis or long-time aficionados. We're excited that Manitoba's adult consumers will have the opportunity to discover our thoughtfully developed brands and products."

Under the terms of the Agreement, the Company will supply up to 2.7 million grams of cannabis and cannabis derivative products in the first year of the agreement, including both Ontario and BC dried flower, pre-rolls and cannabis oils. The wide range of products will be available for sale at licensed retailers across the province. It is anticipated that additional products currently being developed by Aphria, such as vapes and edibles, will also be made available in Manitoba when authorized for sale under the Cannabis Act.

"This partnership with Manitoba represents yet another significant step towards the future as we continue to make history across Canada in the march towards legal sales this fall" said Vic Neufeld, Chief Executive Officer at Aphria. "With our annual production capacity reaching 255,000 kg in early 2019 and our recently announced partnership with Great North Distributors, we are incredibly prepared to meet the anticipated demand in Manitoba and across Canada."

We Have a Good Thing Growing

About Aphria

Aphria is a leading global cannabis company driven by an unrelenting commitment to our people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The Company's portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.

For more information, visit: aphria.ca

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations with respect to actual production volumes, expectations of shipments to Provincial Liquor Control Boards expectations for future growing capacity and costs, the completion of any capital project or expansions, and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Aphria Inc.